Because PR expression is primarily estrogen-induced in a majority of PR+ tissues and cancer models, isolating the unique contributions of progesterone/PR in breast cancer biology can be difficult to study in breast cancer models without the confounding (i.e., proliferative) effects of estrogen/ER. This evidence concerns the gene ESR1 and cancer.